News

US FDA extends review timeline of Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II: Rockville, Maryland Wednesday, August 20, 2025, 18:00 Hrs [IST] ...
China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma: Shanghai Wednesday, August 20, 2025, 16:00 H ...
Medanta Hospital highlights growing burden of resistant hypertension despite medication in India: Our Bureau, Bengaluru Wednesday, August 20, 2025, 16:30 Hrs [IST] Medanta Hospita ...
CitiusTech acquires Health Data Movers to improve hospitals with Epic Systems implementation: Our Bureau, Bengaluru Wednesday, August 20, 2025, 16:40 Hrs [IST] CitiusTech, a leadi ...
Dr Lal PathLabs (DLPL) has adopted a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. The lab major said that has become the first laboratory ...
Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...
MedImpact offers low cost, unbranded ustekinumab-aekn biosimilar: San Diego, California Wednesday, August 20, 2025, 13:00 Hrs [IST] MedImpact Holdings Inc., the largest independen ...
Lupin launches bosentan tablets for oral suspension in US with 180-day exclusivity: Our Bureau, Mumbai Wednesday, August 20, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limite ...
Boehringer Ingelheim & Palatin Technologies ink global research collaboration and licensing pact to develop innovative therapy for retinal diseases: Ingelheim, Germany Wednesday, ...
RemeGen and Santen ink exclusive licensing agreement for ophthalmic innovative drug RC28-E in Greater China and Asian countries: Yantai, China Wednesday, August 20, 2025, 11:00 Hr ...
PCI Biotech discontinues development of PCL technology and evaluation of future operations: Oslo, Norway Wednesday, August 20, 2025, 14:00 Hrs [IST] PCI Biotech Holding ASA, a bio ...